STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
70 hedge funds and large institutions have $116M invested in Stemline Therapeutics, Inc. in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 15 closing their positions.
Holders
70
Holders Change
-5
Holders Change %
-6.67%
% of All Funds
1.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
22
Reduced
22
Closed
15
Calls
$1.75M
Puts
$575K
Net Calls
+$1.18M
Net Calls Change
-$52K
Top Buyers
| 1 |
1
Axa
Paris,
France
|
$5.79M |
| 2 |
AG
2
Artal Group
Luxembourg
|
$2.3M |
| 3 |
LSC
3
Lyon Street Capital
Sausalito,
California
|
$1.16M |
| 4 |
CCI
4
Columbus Circle Investors
|
$3.13M |
| 5 |
IBT
5
International Biotechnology Trust
London,
United Kingdom
|
$4.17M |
